Ex parte HAUSER et al. - Page 3




          Appeal No. 97-0840                                                          
          Application 08/159,405                                                      


          (Answer, page 2).   We reverse this rejection for reasons2                                                          
          which follow.                                                               





          OPINION                                                                     
               The examiner’s rejection of claims 2-9 “as being                       
          indefinite and incomplete” states that the “claims are                      
          considered to recite a process by only describing the desired               
          effect wanted, i.e. using a [sic, an] ink formulated to result              
          in the greatest possible degree of metamerism between a                     
          reference ink and the formulated ink.” (Answer, page 2).  The               
          examiner further states that there are no parameters of how                 
          the ink is formulated and it would take an “inventive step” to              
          formulate the ink and determine that the ink has the “greatest              
          possible degree of metamerism” from the reference ink (Id.).                




               2The examiner’s Answer does not specify what paragraph of § 112 is relied upon
          as the statutory basis for the rejection (see the Answer, page 2).  Since no new ground
          of rejection has been made in the Answer (Answer, page 2, paragraph (12)) and the final
          rejection contains only a rejection of claims 2-9 under                     
          § 112, paragraph two, we consider the rejection in the Answer as based on paragraph two
          of § 112.  However, note our discussion of 35 U.S.C. § 112, first paragraph, infra.
                                          3                                           




Page:  Previous  1  2  3  4  5  6  7  8  Next 

Last modified: November 3, 2007